期刊论文详细信息
BMC Medicine
The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction
Michael Berk3  Shuzheng Liu1  Jianhui Chen2  Dongfeng Zhang2  Xingde Liu1  Yiming Wang3 
[1]Department of Cardiology, Hospital Affiliated to Guiyang Medical University, 28 Guiyi Street, Guiyang City, 550004, Guizhou, China
[2]Department of Psychiatry, Hospital Affiliated to Guiyang Medical University, 28 Guiyi Street, Guiyang City, 550004, Guizhou, China
[3]School of Medicine, Deakin University, 1 Gheringhap Street, Geelong, VIC 3220, Australia
关键词: comorbidity.;    cardiac;    stress;    myocardium;    apoptosis;    myocardial infarction;    major depressive disorder;   
Others  :  857198
DOI  :  10.1186/1741-7015-11-32
 received in 2012-05-08, accepted in 2013-02-08,  发布年份 2013
PDF
【 摘 要 】

Background

There is an increased incidence of major depressive disorder (MDD) in individuals after myocardial infarction (MI), but the pathophysiological processes mediating this association are unclear. Our previous study demonstrated an increase in pro-apoptotic pathways in the myocardium and hippocampus in MDD, which was reversed by venlafaxine. This study aimed to attempt to confirm the effects of apoptosis vulnerability markers on the myocardium in a model of depression after myocardial infarction.

Methods

Rats were divided into four groups: sham (N = 8), depression (N = 8, chronic mild unpredictable stress and separation were used in the depression group), MI (N = 13) and post-MI depression (N = 7). The rats in all four groups underwent the same open field and sucrose preference behavioral tests. Evan Blue staining was used to determine the area at risk of myocardial infarction in the left ventricle, and 2,3,5-triphenyl tetrazolium chloride (1.5% TTC) dye was used to detect the size of the myocardial infarction. The expression of bax and bcl-2 protein in the myocardium was investigated by immunohistochemistry, and the mRNA expression of bax, bcl-2 and caspase-3 in the myocardium was investigated by real time RT-PCR. Apoptosis was estimated in the myocardium by measuring the Bax:Bcl-2 ratio.

Results

In the depression and post-MI depression rats, there were significantly decreased movements and total sucrose consumption, modeling behavioral deficits and an anhedonic-like state. In terms of myocardial infarction size, no difference was seen between the MI and post-MI depression groups. There was an up-regulated Bax:Bcl-2 ratio in the depression, MI and post-MI depression groups. Furthermore, in the latter group, there was a greater up-regulated Bax:Bcl-2 ratio. However, caspase-3 did not differ among the four groups.

Conclusions

These results of this animal model suggest that active pro-apoptotic pathways may be involved in the nexus between myocardial infarction and depression. This mechanism may be germane to understanding this relationship in humans.

【 授权许可】

   
2013 Wang et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140723071909818.pdf 985KB PDF download
Figure 1. 123KB Image download
64KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Charlson FJ, Stapelberg NJ, Baxter AJ, Whiteford HA: Should global burden of disease estimates include depression as a risk factor for coronary heart disease? BMC Med 2011, 9:1-6. BioMed Central Full Text
  • [2]Ikenouchi-Sugita A, Yoshimura R, Kishi T, Umene-Nakano W, Hori H, Hayashi K, Katsuki A, Ueda N, Iwata N, Nakamura J: Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report. Hum Psychopharmacol 2011, 26:531-534.
  • [3]May HT, Horne BD, Carlquist JF, Sheng X, Joy E, Catinella AP: Depression after coronary artery disease is associated with heart failure. J Am Coll Cardiol 2009, 53:1440-1447.
  • [4]Spertus JA, McDonell M, Woodman CL, Fihn SD: Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am Heart J 2000, 140:105-110.
  • [5]Pignay-Demaria V, Lespérance F, Demaria FG, Frasure-Smith N, Perrault LP: Depression and anxiety and outcomes of coronary artery bypass surgery. Ann Thorac Surg 2003, 75:314-321.
  • [6]Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P: Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-151.
  • [7]Strik JJ, Honig A, Maes M: Depression and myocardial infarction: relationship between heart and mind. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:879-892.
  • [8]von Känel R, Begré S: Depression after myocardial infarction: unraveling the mystery of poor cardiovascular prognosis and role of beta-blocker therapy. J Am Coll Cardiol 2006, 48:2215-2217.
  • [9]van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, van den Brink RH, van den Berg MP: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004, 66:814-822.
  • [10]Carney RM, Freedland KE: Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003, 54:241-247.
  • [11]Fauerbach JA, Bush DE, Thombs BD, McCann UD, Fogel J, Ziegelstein RC: Depression following acute myocardial infarction: a prospective relationship with ongoing health and function. Psychosomatics 2005, 46:355-361.
  • [12]Nuñez G, Clarke MF: The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994, 4:399-403.
  • [13]White E: Life, death and the pursuit of apoptosis. Genes Dev 1996, 10:1-15.
  • [14]Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J: Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 1997, 124:1239-1249.
  • [15]Cory S, Huang DC, Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003, 22:8590-8607.
  • [16]Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH: Apoptotic proteins in the temporal cortex in schizophrenia: high bax/bcl-2 ratio without caspase-3 activation. Am J Psychiatry 2004, 161:109-115.
  • [17]Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619.
  • [18]Wann BP, Bah TM, Kaloustian S, Boucher M, Dufort AM, Le Marec N, Godbout R, Rousseau G: Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline. J Psychopharmacol 2009, 23:451-459.
  • [19]Fan TJ, Han LH, Cong RS, Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin 2005, 37:719-727.
  • [20]Boucher M, Wann BP, Kaloustian S, Massé R, Schampaert E, Cardinal R, Rousseau G: Sustained cardioprotection afforded by A2A adenosine receptor stimulation after 72 hours of myocardial reperfusion. J Cardiovasc Pharmacol 2005, 45:439-446.
  • [21]Wann BP, Boucher M, Kaloustian S, Nim S, Godbout R, Rousseau G: Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry 2006, 59:430-433.
  • [22]Girard SA, Bah TM, Kaloustian S, Lada-Moldovan L, Rondeau I, Tompkins TA, Godbout R, Rousseau G: Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr 2009, 102:1420-1425.
  • [23]Wann BP, Bah TM, Boucher M, Courtemanche J, Le Marec N, Rousseau G, Godbout R: Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J Psychiatry Neurosci 2007, 32:11-16.
  • [24]Wang Y, Xiao Z, Liu X, Berk M: Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium. Hum Psychopharmacol 2011, 26:95-101.
  • [25]Willner P, Muscat R, Papp M: Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992, 16:525-534.
  • [26]Wu JC, Chen IY, Wang Y, Tseng JR, Chhabra A, Salek M, Min JJ, Fishbein MC, Crystal R, Gambhir SS: Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 2004, 110:685-691.
  • [27]Wehrens XH, Kirchhoff S, Doevendans PA: Mouse electrocardiography: an interval of thirty years. Cardiovasc Res 2000, 45:231-237.
  • [28]Moreau JL, Jenck F, Martin JR, Mortas P, Haefely WE: Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 1992, 2:43-49.
  • [29]Willner P, Towell A, Sampson D, Sophokleous S, Muscat R: Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
  • [30]Montgomery KS, Mackey J, Thuett K, Ginestra S, Bizon JL, Abbott LC: Chronic, low-dose prenatal exposure to methylmercury impairs motor and mnemonic function in adult C57/B6 mice. Behav Brain Res 2008, 191:55-61.
  • [31]Grippo AJ, Beltz TG, Weiss RM, Johnson AK: The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 2006, 59:309-316.
  • [32]Katz RJ, Roth KA, Carroll BJ: Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981, 5:247-251.
  • [33]Erdodan F, Golgeli A, Arman F, Ersoy AO: The effects of pentylenetetrazole induced status epilepticus on behavior, emotional memory and learning in rats. Epilepsy Behav 2004, 5:388-393.
  • [34]Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, Wiborg O: Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res 2009, 198:136-141.
  • [35]Zhang H, Liu L, Huang G, Zhou L, Wu W, Zhang T, Huang H: Protective effect of electroacupuncture at the Neiguan point in a rabbit model of myocardial ischemia-reperfusion injury. Can J Cardiol 2009, 25:359-563.
  • [36]McConnell S, Jacka FN, Williams LJ, Dodd S, Berk M: The relationship between depression and cardiovascular disease. Int J Psychiatry Clin Pract 2005, 9:157-167.
  • [37]Ho YL, Chen CL, Hsu RB, Lin LC, Huang PJ: The correlation between expression of apoptosis-related proteins and myocardial functional reserve evaluated by dobutamine stress echocardiography in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 2003, 16:931-936.
  • [38]van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ: Myocyte apoptosis in heart failure. Cardiovasc Res 2005, 67:21-29.
  • [39]Pasco JA, Nicholson GC, Ng F, Henry MJ, Williams LJ, Kotowicz MA, Hodge JM, Dodd S, Kaczynski F, Gama CS, Berk M: Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica 2008, 20:112-116.
  • [40]Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Kono Y, Umemura T, Nakamura S: Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002, 143:448-455.
  • [41]Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2012, in press.
  • [42]Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D: Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 2007, 21:123-132.
  • [43]Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998, 101:1326-1342.
  • [44]Wernig F, Xu Q: Mechanical stress-induced apoptosis in the cardiovascular system. Prog Biophys Mol Biol 2002, 78:105-137.
  • [45]Lancel S, Joulin O, Favory R, Goossens JF, Kluza J, Chopin C, Formstecher P, Marchetti P, Neviere R: Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 2005, 111:2596-2604.
  • [46]Frantz S, Ducharme A, Sawyer D, Rohde LE, Kobzik L, Fukazawa R, Tracey D, Allen H, Lee RT, Kelly RA: Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol 2003, 35:685-694.
  • [47]Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JD, Schneider HG: High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 2006, 296:1353-1355.
  • [48]Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M: Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychophrmacol Biol Psychiatry 2011, 35:769-783.
  文献评价指标  
  下载次数:18次 浏览次数:20次